Francisco Baller to retire; Peter Stenico is appointed in Presidency Region International

Content of article

AD HOC announcement has removed from ART. 53 Six Rules for Swiss

Content of article

Content of article

• President Region International, Francisco Baller, retiring March 1, 2025, after 34 years of service
• Peter Stenico, now Globles Platform Platform Platform Platform Platform Platforms and President Samazaz Austria, at the same time are the Presidency Region International and the Sandoz Committee member

Basel, February 3, 2025 – Sandoz, Global Leader in the General Mices and Biosimand, announced the Francisco Balkester, the International President Sandoz 1, 2025. America and Europe, while developing very different talents in the region. He is a member of the Health Advisory Council and the Miami Herbert Business School policy policy.

Content of article

Drawing from a solid bench for central leaders, Peter Stenico will win Francisco. Peter was appointed Head of the world platform, Biosimand, January 2023 and led the Biandoz Biandoz. Earlier, Peter held the position of the Head of Country and Sandoz’s general Manager in Germany and he was also president of Germany Association (Pro Generika). Peter joined the Sandoz in 2002 and won the largest Biosimimers industries and a general industry by using various roles coverage strategy, M & A and Arrange Levels of the world, district and local.

Richard Saynor, Sandoz Chief Executive Officer, “Francisco has spent more than three decades that took unique and more fishing roles. I thank our people and our people. Many of his many understoods to the senior Sandoz committee. I wish Francisco all the best for his retirement.

Content of article

Content of article

I’m very proud of the greatest wealth of the experience we have in the Sandoz. Like Francisco, Peter can look back to a successful work for many years in Sandoz and will bring this innovative program to his new role and high-scale Sandoz. I accept her in the team and wish a great success in taking Sandoz Region International to the next level of growth. “

And a statement
This media release contains a positive, providing statements in relation to future performance. These statements are made on the basis of the observation and unity of the future events and business operations during the statements are performed. They are subject to risks and uncertainty including, but are not preserved, future economic conditions, exchange rates, legal provisions, competitors, competitors and other factors outside the Sandoz. In the event of these risks or more than these risks or unsure of the basic consideration of the imperfection, the real results may vary from predicted or expectations. Each Bible-looking statement speaks only like a day of some statement, and Sandoz has vowed no obligation to revitalize or review any previous looks, unless required by law.

Content of article

About Sandoz
Sandoz (six: SDZ; SDZNY: SDZny) is a global leader in regular medicines and bioyar, a growth plan conducted by its intention: the cost of patients. More than 20,000 people of 100 people work together to ensure 800 million patients are offered by Sandoz, who created the global health and a major social impact. Its leading portfolio of about 1,5500 products deal with diseases that are common in cancer. Headquartered Basel, Switzerland, a surprise traced its heritage heritage to 1886. Its history of success includes the 1951 biosimir, and the first sandoz in 2006. By sandoz recording USD sale 9.6. billion.

Contacts

Confirm

• Media Relex_Leader announcement

Content of article